Ismael Lares-Asseff | Pharmacology | Lifetime achievement Award

Posted on by ScienceFather

Assoc. Prof. Dr. Ismael Lares-Asseff | Pharmacology | Lifetime achievement Award

Assoc. Prof. Dr. Ismael Lares-Asseff, Instituto Politécnico Nacional, CIIDIR Durango, Mexico

Dr. Ismael Lares-Asseff, a prominent Mexican researcher, holds a degree in Medicine from UJED and a specialty in Pediatrics from IMAN and UNAM. He earned his Master’s and Ph.D. in Medical Sciences from UNAM, receiving the prestigious “Gabino Barreda Medal.” Mentored by renowned researcher Dr. Joaquín Cravioto, Dr. Lares founded Latin America’s first Clinical Pharmacokinetics Laboratory in 1982. His work spans pediatric pharmacokinetics, malnutrition, and pharmacogenetics among diverse ethnic groups, and he authored influential books like Clinical Pharmacology in Pediatrics and Pharmacogenomics in Latin America. With 190 publications, 671 citations, and numerous awards, he is a leader in personalized medicine.

 

Publication Profile

Scopus

Orcid

Background and Academic Achievements

Assoc. Prof. Dr. Ismael Lares-Asseff holds a distinguished background in medicine, earning degrees and accolades throughout his extensive career. With an MD from the Universidad Juárez del Estado de Durango (UJED), he specialized in Pediatrics through the Children’s Hospital of IMAN and the National Autonomous University of Mexico (UNAM). His academic journey culminated in a Master’s and Doctorate in Medical Sciences from UNAM, where he was awarded the “Gabino Barreda Medal” for his outstanding academic achievements.

Contributions to Pediatric Research and Clinical Pharmacokinetics

Under the mentorship of Dr. Joaquín Cravitoto, a globally respected figure in pediatric research, Dr. Lares-Asseff developed Mexico’s first Clinical Pharmacokinetics Laboratory in 1982. His early research primarily focused on understanding the impact of malnutrition on pediatric pharmacokinetics, producing findings published in prestigious journals. These works led to his internationally recognized book, Clinical Pharmacology in Pediatrics: Pharmacokinetics and Pharmacogenomics, awarded by the Mexican Academy of Pediatrics.

Conclusion

Assoc. Prof. Dr. Ismael Lares-Asseff is an ideal candidate for the Research for Lifetime Achievement Award. His contributions to pediatric pharmacology, pharmacogenetics, and personalized medicine embody a lifelong commitment to advancing medical science and patient care.

 

Publication Top Notes

  • 🧬 Influence of Age, Gender, and BMI on IV Pharmacokinetics of Buprenorphine in Children Undergoing Orthopedic Surgery, Rivera-Espinosa, L., Vicencio-Rosas, E., et al., Dose-Response, 2024, 0 citations.
  • 👨‍⚕️ Population Pharmacokinetics and Pharmacodynamics of L-asparaginase and Its Impact on Pancreatitis in Leukemia Patients, Gándara-Mireles, J.A., Lares-Asseff, I., et al., Drug and Chemical Toxicology, 2024, 0 citations.
  • 💉 Nutritional Status as a Risk Factor for Doxorubicin Cardiotoxicity in Mexican Children with ALL, Gándara-Mireles, J.A., Lares-Asseff, I., et al., Nutrition and Cancer, 2024, 0 citations.
  • 🧪 Impact of SNPs and Nutrition on Doxorubicin Pharmacokinetics and Cardiotoxicity in Leukemia Patients, Gándara-Mireles, J.A., Lares-Asseff, I., et al., Journal of Oncology Pharmacy Practice, 2023, 3 citations.
  • 🌎 Barriers to Pharmacogenomics in Latin America and the Caribbean: Drug/Gene Pairs, Salas-Hernández, A., Galleguillos, M., et al., Frontiers in Pharmacology, 2023, 9 citations.
  • 📝 Pharmacogenetics and Pharmacogenomics in Latin America: Perspectives, López-Cortés, A., Esperón, P., Lares-Asseff, I., et al., Frontiers in Pharmacology, 2023, 3 citations.
  • 🐾 Silver Nanoparticles in Treating Distemper in Dogs: A Clinical Trial, Gastelum-Leyva, F., Pena-Jasso, A., et al., Viruses, 2022, 2 citations.
  • 🔬 Mitochondrial Dysfunction Caused by Zinc Oxide Nanoparticles, Patrón-Romero, L., et al., Crystals, 2022, 16 citations.
  • 🧬 Effect of Levetiracetam on Placental Transporter Gene Expression in Mice, Blanco-Castañeda, R., et al., Epilepsia, 2022, 0 citations.
  • ❤️ Genetic Polymorphisms and Doxorubicin Cardiotoxicity in Children with ALL, Gándara-Mireles, J.A., Lares-Asseff, I., et al., Pharmacogenetics and Genomics, 2021, 8 citations.

 

 

 

Shubham Sharma | Pharmacology | Best Researcher Award

Posted on by ScienceFather

Shubham Sharma | Pharmacology | Best Researcher Award

Dr Shubham Sharma, Pfizer, United States

Dr. Shubham Sharma is a leading computational modeler with 8+ years of expertise in theoretical materials science, physics, and chemistry. Holding a Ph.D. in Chemical & Environmental Engineering from Brown University (2021), he specializes in atomistic modeling and solid-form design, notably working at Pfizer where he leads drug de-risking efforts. His research in catalysis, electrochemistry, and crystal structure predictions has earned him over 10 Pfizer Bravo awards. Dr. Sharma’s groundbreaking work is recognized globally, including invited talks at major conferences, advancing both pharmaceutical and renewable energy applications. 💻🔬💊⚡

Publication Profile

Google Scholar

Education

This individual holds a PhD in Chemical & Environmental Engineering from Brown University, USA (2016-2021) 🎓, where they conducted research under the guidance of Andrew A. Peterson 🧑‍🔬. Their academic journey began with a Bachelor of Technology (B. Tech) in Chemical Engineering from the Heritage Institute of Technology, India (2012-2016) 🛠️. With a strong foundation in chemical engineering, they have pursued advanced studies focusing on environmental solutions and sustainability 🌍. Their education showcases a dedication to addressing global environmental challenges through innovative engineering approaches and cutting-edge research 🌱📘.

Work Experience

Currently serving as a Senior Scientist in Computational Materials Science at Pfizer Inc. (July 2022 – present) 🧑‍🔬, this individual leads the Solid Form Design Center (SFDC) focused on de-risking potential drug molecules through advanced statistical and quantum mechanical modeling 💊. They contributed to the success of Zavegepant (Zavzpret™) and Rimegepant (Nurtec™) 🌟. As a core member of the Crystal Structure Prediction team, they specialize in electronic structure theory, density functional theory, and atomistic modeling 🧬. They also collaborate with global industrial and academic partners, lead multiple research proposals, and mentor colleagues in computational science 🔬💻.

Selected conference presentations

Sharma has delivered numerous invited talks and presentations globally 🌍. In 2024, they presented on multi-polymorphic systems at the Crystal Form Consortium Symposium (UK) and computational strategies in pharmaceutical research at UConn (US) and IISER (India) 🧪. Sharma also discussed electrocatalysis at the 8th Global Webinar on Materials Science & Engineering in 2023 🧑‍🏫. Other notable presentations include de-risking medicines at AAPS NERDG (2024) and several studies on oxygen reduction reactions and catalytic properties at AIChE, NECS, ECS, and MRS conferences 🎤. Their work spans computational modeling and applied research in materials science and electrocatalysis ⚛️.

Research Focus

The research focus of Sharma spans electrochemistry, catalysis, and materials science. Sharma investigates the design and stability of catalysts, particularly Pt-based and CoPt alloys, for fuel cells and oxygen reduction reactions (ORR) ⚡️🔋. His work includes dynamic stability, reaction barriers, and potential-controlled reactions, using advanced techniques like density functional theory (DFT) and experimental-theoretical integration. He also explores solid form derisking in pharmaceuticals 💊 and carbon electrodes in redox flow batteries. Sharma’s studies contribute to cleaner energy and advanced catalytic systems 🌍🔬, emphasizing electrochemical stability and performance improvement in energy devices.

 

Publication Top Notes

Hard-magnet L10-CoPt nanoparticles advance fuel cell catalysis

Anisotropic Strain Tuning of L10 Ternary Nanoparticles for Oxygen Reduction

Face-centered tetragonal (FCT) Fe and Co alloys of Pt as catalysts for the oxygen reduction reaction (ORR): A DFT study

Ordered CoPt oxygen reduction catalyst with high performance and durability

Metal dissolution from first principles: Potential-dependent kinetics and charge transfer

Assessment of carbon monoxide exposure in roadside food-vending shanties using coal cookstoves in Kolkata, India

Dynamic stability of Pt-based alloys for fuel-cell catalysts calculated from atomistics

Conclusion

Dr. Shubham Sharma’s innovative research in computational modeling and materials science, alongside his leadership in both academic and industrial collaborations, makes him an exceptional candidate for the Best Researcher Award. His contributions have not only advanced pharmaceutical drug design but also impacted renewable energy research, marking him as a distinguished leader in his field.

Divya Jain | Pharmacology Award | Women Researcher Award

Posted on by ScienceFather

Dr. Divya Jain | Pharmacology Award | Women Researcher Award

Dr. Divya Jain, Uttaranchal University, India

Dr. Divya Jain is an accomplished microbiologist, holding a Ph.D. in Microbiology from Banasthali Vidyapith, Rajasthan (2023), an M.Sc. in Microbiology from Graphic Era University, Dehradun (2018), and a B.Sc. in Biotechnology from Banasthali Vidyapith (2016). She currently serves as an Assistant Professor at Uttaranchal University, Dehradun, bringing extensive expertise in microbiology to the Department of Microbiology. Her previous roles include an Associate Research Fellow at the Integrative Centre for Research & Innovation in Biology in Chandigarh. Dr. Jain also completed a notable internship in content and academic writing with The Applied Biology & Chemistry Journal. 📚🔬✨

Publication profile

Orcid

Google Scholar

🎓 Education

Dr. Divya Jain holds a Ph.D. in Microbiology from Banasthali Vidyapith, Rajasthan (2023), an M.Sc. in Microbiology from Graphic Era University, Dehradun (2018), and a B.Sc. in Biotechnology from Banasthali Vidyapith (2016). She completed her high school education in PCB from S.D.R.R Public School, Shamli (2013). 📘🔬

🏢 Work Experience

Currently an Assistant Professor at Uttaranchal University, Dehradun, Dr. Jain also served as an Associate Research Fellow at the Integrative Centre for Research & Innovation in Biology, Chandigarh. 📚🔬

🏅 Certificates and Awards

Dr. Jain has earned several accolades, including the Innovative Article Award and the Excellence in Research Award. She has also completed certificate courses in microbiology, forensic science, and RJ-Ing. 🏆📜

 

Research Focus 🔬🌍

Dr. Divya Jain’s research is primarily focused on microbiology, environmental science, and pharmacology. Her work includes studying microbial pollution, particularly coliform bacteria, and their environmental impact. She has also contributed significantly to sustainable agriculture through research on plant growth-promoting microorganisms and mycorrhiza. Dr. Jain explores the pharmacological applications of natural compounds, such as propolis and medicinal plants, for cancer therapy and liver protection. Her research extends to evaluating potential inhibitors for SARS-CoV-2 and other viral infections, emphasizing bioactive compounds from natural sources. Her multifaceted research underscores her dedication to addressing critical global health and environmental challenges. 🌱🧬🧪

 

Publication Top Notes

  • “Microbial pollution of water with special reference to coliform bacteria and their nexus with environment” 🌊🦠 (110 citations, 2021)
    S Some, R Mondal, D Mitra, D Jain, D Verma, S Das
    Energy Nexus 1, 100008
  • “Role of mycorrhiza and its associated bacteria on plant growth promotion and nutrient management in sustainable agriculture” 🌱🔬 (90 citations, 2020)
    D Mitra, N Uniyal, P Panneerselvam, A Senapati, AN Ganeshamurthy
    International Journal of Life Sciences and Applied Sciences 1 (1), 1-1
  • “Propolis: An update on its chemistry and pharmacological applications” 🍯⚗️ (73 citations, 2022)
    R Hossain, C Quispe, RA Khan, ASM Saikat, P Ray, D Ongalbek, …
    Chinese medicine 17 (1), 100
  • “Tobacco Smoking and Liver Cancer Risk: Potential Avenues for Carcinogenesis” 🚬🔬 (53 citations, 2021)
    D Jain, P Chaudhary, N Varshney, KS Bin Razzak, D Verma, …
    Journal of Oncology 2021 (1), 5905357
  • “Potential inhibitors of SARS-CoV-2 (COVID 19) proteases PLpro and Mpro/3CLpro: molecular docking and simulation studies of three pertinent medicinal plant natural components” 🧬🌿 (44 citations, 2021)
    D Verma, D Mitra, M Paul, P Chaudhary, A Kamboj, H Thatoi, P Janmeda, …
    Current Research in Pharmacology and Drug Discovery 2, 100038
  • “Biosynthesis of secondary metabolites based on the regulation of microRNAs” 🧬🧪 (33 citations, 2022)
    R Hossain, C Quispe, ASM Saikat, D Jain, A Habib, P Janmeda, MT Islam, …
    BioMed Research International 2022 (1), 9349897
  • “Hepatoprotective activity of medicinal plants: A mini review” 🌿🛡️ (29 citations, 2020)
    D Jain, P Chaudhary, A Kotnala, R Hossain, K Bisht, MN Hossain
    Journal of Medicinal Plants Studies 8 (5), 183-188
  • “Quercetin and/or Ascorbic Acid Modulatory Effect on Phenobarbital-Induced Sleeping Mice Possibly through GABAA and GABAB Receptor Interaction Pathway” 💤🍊 (25 citations, 2021)
    R Hossain, K Al-Khafaji, RA Khan, C Sarkar, MS Islam, D Dey, D Jain, …
    Pharmaceuticals 14 (8), 721
  • “Anticancer effects of acteoside: Mechanistic insights and therapeutic status” 🧬🎗️ (22 citations, 2022)
    RA Khan, R Hossain, P Roy, D Jain, ASM Saikat, APR Shuvo, M Akram, …
    European Journal of Pharmacology 916, 174699
  • “Carcinogenic effects of N-nitroso compounds in environment” 🚫🦠 (22 citations, 2020)
    D Jain, P Chaudhary, N Varshney, P Janmeda
    Environment Conservation Journal 21 (3), 25-41

Patricia Rijo |Pharmacology, Toxicology | Best Researcher Award

Posted on by ScienceFather

Assoc Prof Dr. Patricia Rijo |Pharmacology, Toxicology | Best Researcher Award

Assoc Prof Dr, Patricia Rijo, Universidade Lusófona, Portugal

Assoc Prof Dr. Patricia Rijo is a distinguished academic at Universidade Lusófona in Portugal. With expertise in [mention her field or area of specialization], Dr. Rijo has contributed significantly to [mention any notable contributions or achievements, such as research, publications, or projects]. Her dedication to [mention any relevant causes or academic interests] underscores her commitment to advancing knowledge in her field. Dr. Rijo’s academic leadership and mentorship inspire both colleagues and students alike at Universidade Lusófona.

Publication profile

Scopus

Education

PhD in Pharmacy (specialty in Medicinal Chemistry and Therapeutics) with Distinction, Faculdade de Farmácia da Universidade de Lisboa, 2003.,Master’s Degree (MSc) in Medicinal Chemistry, Faculdade de Farmácia da Universidade de Lisboa, 2003.,Bachelor’s Degree in Chemistry, Faculdade de Ciências da Universidade de Lisboa, 1999.

Professional Experience

Dr. Hyunsook Lee has had a distinguished professional career in academia and research 👩‍🔬. She began as a Research Scientist at Mogam Biotech Research Institute in Korea (1992. Mar – 1994. May) 🔬 and was promoted to Senior Research Scientist (1994. May – 1996. Aug) 🧬. She then transitioned to academia as a Research Assistant Professor at Ewha Womans University (2002. Sept – 2003) 🧪. In 2004, she joined the Dept. of Biological Sciences at Seoul National University (SNU) as an Assistant Professor 📚, advancing to Associate Professor in 2008 and earning early tenure in 2010 🌟. By 2012, she became a full Professor at SNU 🌍. Dr. Lee has also served in several key administrative roles, including Vice Dean of Planning for the College of Natural Sciences (2015 July – 2017 June) 📅, and Dean for Research Affairs at SNU (2021. Feb – 2023. Feb) 🎓. She has been the Head of the AI-Bio Research Center since 2023 🧠🔬 and co-founded Next & Bio in 2019, which later merged with Kolmar Holdings in 2022 💼. Her visiting scientist positions include stints at the Dana Farber Cancer Institute (2010. Aug – 2011. July) 🧬 and Samsung Advanced Institute of Technology (2020. Aug – 2021. Feb) 🏥.

Academic Positions:

Associate Professor at Universidade Lusófona de Humanidades e Tecnologias (ULHT), since June 2020.,Assistant Professor at ULHT (2011-2020).,Coordinator Professor at Escola Superior de Ciências da Saúde (2011-2016).,Assistant at ULHT (2005-2010).,Invited Assistant Professor at Escola Superior de Saúde Ribeiro Sanches (2002-2011).,Monitor at Faculdade de Farmácia da Universidade de Lisboa (2001-2005).

Awards and Honors:

Egon Stahl-Award in Bronze from Society for Medicinal Plant and Natural Product Research (2022).,Various awards for scientific presentations and research contributions.

Additional Skills and Activities:

  • Languages: Proficiency in Portuguese (C2), English (B2), Spanish (B1), French (A2).
  • Supervision: Supervised numerous PhD and Master’s students.
  • Project Leadership: Participation and leadership in multiple research projects.

Publications:

  • Anticancer diterpenes of African natural products: Mechanistic pathways and preclinical developments
    • Authors: Bangay, G., Brauning, F.Z., Rosatella, A., Efferth, T., Rijo, P.
    • Journal: Phytomedicine, 2024, 129, 155634
    • Abstract: This article likely discusses the mechanistic pathways through which diterpenes from African natural products exhibit anticancer properties, as well as their development in preclinical studies.
  • Glycyrrhizic Acid Nanoparticles Subside the Activity of Methicillin-Resistant Staphylococcus aureus by Suppressing PBP2a
    • Authors: Rijo, P., Abuamara, T.M.M., Ali Lashin, L.S., Abd El Maksoud, A.I., Hassan, A.
    • Journal: Pharmaceuticals, 2024, 17(5), 589
    • Abstract: This article likely explores the use of glycyrrhizic acid nanoparticles to combat methicillin-resistant Staphylococcus aureus (MRSA) by targeting the penicillin-binding protein PBP2a.
  • Halimane Derivatives from Plectranthus ornatus Codd. as Novel Anti-cancer Agents
    • Authors: Bangay, G., Brauning, F.Z., Kowalczyk, T., Sitarek, P., Rijo, P.
    • Journal: Biomedicine and Pharmacotherapy, 2024, 174, 116516
    • Abstract: This article likely investigates the anticancer potential of halimane derivatives from Plectranthus ornatus.
  • Solving the antibacterial resistance in Europe: The multipronged approach of the COST Action CA21145 EURESTOP
    • Authors: Seguin-Devaux, C., Mestrovic, T., Arts, J.J., Rijo, P., Mori, M.
    • Journal: Drug Resistance Updates, 2024, 74, 101069
    • Abstract: This editorial likely outlines the efforts and strategies of the COST Action CA21145 EURESTOP in addressing antibacterial resistance in Europe.
  • Biological Activity of 6,7-Dehydroxyroyleanone and Derivatives Obtained from Plectranthus aliciae (Codd) A.J.Paton
    • Authors: Filipe, M.S., Domínguez-Martín, E.M., Pires, T.C.S.P., Barros, L., Rijo, P.
    • Journal: ACS Omega, 2024, 9(16), pp. 18113–18118
    • Abstract: This article likely details the biological activities of 6,7-dehydroxyroyleanone and its derivatives sourced from Plectranthus aliciae.
  • Exploring the Anticancer Potential of Semisynthetic Derivatives of 7α-Acetoxy-6β-hydroxyroyleanone from Plectranthus sp.: An In Silico Approach
    • Authors: Merecz-Sadowska, A., Isca, V.M.S., Sitarek, P., Rijo, P., Zajdel, R.
    • Journal: International Journal of Molecular Sciences, 2024, 25(8)
    • Abstract: This article likely explores the anticancer potential of semisynthetic derivatives of a specific compound from Plectranthus species using computational methods.
  • Anticancer Effects of Abietane Diterpene 7α-Acetoxy-6β-hydroxyroyleanone from Plectranthus grandidentatus and Its Semi-Synthetic Analogs: An In Silico Computational Approach
    • Authors: Isca, V.M.S., Sitarek, P., Merecz-Sadowska, A., Rijo, P., Kowalczyk, T.
    • Journal: Molecules, 2024, 29(8), 1807
    • Abstract: This article likely investigates the anticancer effects of abietane diterpene and its analogs from Plectranthus grandidentatus using computational techniques.
  • Antibiotic Coordination Frameworks against Antibiotic Resistance: How to Involve Students through Experimental Practices in the Search for Solutions to Public Health Problems
    • Authors: Domínguez-Martín, E.M., Ntungwe, E., Isca, V.M.S., André, V., Rijo, P.
    • Journal: Journal of Chemical Education, 2024, 101(5), pp. 2045–2051
    • Abstract: This article likely discusses educational strategies to involve students in experimental practices to address antibiotic resistance.
  • The Precious Potential of the Sacred Tree Chamaecyparis obtusa (Siebold & Zucc.) Endl. as a Source of Secondary Metabolites with Broad Biological Applications
    • Authors: Górski, K.M., Kowalczyk, T., Picot, L., Ghorbanpour, M., Sitarek, P.
    • Journal: International Journal of Molecular Sciences, 2024, 25(5), 2723
    • Abstract: This review likely highlights the various biological applications of secondary metabolites derived from Chamaecyparis obtusa.
  • Enhancement of Vitamin C’s Protective Effect against Thimerosal-Induced Neurotoxicity in the Cerebral Cortex of Wistar Albino Rats: An In Vivo and Computational Study
    • Authors: Hassan, A., Mohsen, R., Rezk, A., Abd El Maksoud, A.I., Mohamed, A.F.
    • Journal: ACS Omega, 2024, 9(8), pp. 8973–8984
    • Abstract: This article likely explores the neuroprotective effects of vitamin C against thimerosal-induced toxicity using both in vivo and computational methods.